| Roger B Moss, CRNA | |
|
823 Sw Mulvane St, Suite 210, Topeka, KS 66606-1679 | |
| (785) 235-3451 | |
| (785) 235-1435 |
| Full Name | Roger B Moss |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 823 Sw Mulvane St, Topeka, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285698662 | NPI | - | NPPES |
| 100357700A | Medicaid | KS | |
| 145473 | Other | KS | BCBS |
| 100357700D | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 54697 (Kansas) | Primary |
| 163W00000X | Registered Nurse | 54697 (Kansas) | Secondary |
| Entity Name | Labette County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336133362 PECOS PAC ID: 5496664369 Enrollment ID: O20031112000344 |
News Archive
Temple University School of Medicine announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Laura Goetzl, MD, MPH, Professor of Obstetrics, Gynecology and Reproductive Sciences; and Vice Chair of Research and Academic Development at Temple University School of Medicine will pursue an innovative global health and development research project, titled "Maternal Blood Biomarkers to Assess Fetal Neurodevelopment."
At the 2010 ACC conference held in Atlanta, GA, six new studies based on the PAT™ (Peripheral Arterial Tone) signal focused on assessing cardiovascular risk by measuring and improving endothelial health. Of those, two studies from Japan focused on assessing cardiovascular risk in both high and low risk patient populations.
A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident.
Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
› Verified 9 days ago
| Entity Name | Anesthesia Associates Of Topeka Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518933837 PECOS PAC ID: 5698675437 Enrollment ID: O20040109000467 |
News Archive
Temple University School of Medicine announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Laura Goetzl, MD, MPH, Professor of Obstetrics, Gynecology and Reproductive Sciences; and Vice Chair of Research and Academic Development at Temple University School of Medicine will pursue an innovative global health and development research project, titled "Maternal Blood Biomarkers to Assess Fetal Neurodevelopment."
At the 2010 ACC conference held in Atlanta, GA, six new studies based on the PAT™ (Peripheral Arterial Tone) signal focused on assessing cardiovascular risk by measuring and improving endothelial health. Of those, two studies from Japan focused on assessing cardiovascular risk in both high and low risk patient populations.
A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident.
Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roger B Moss, CRNA 823 Sw Mulvane St, Suite 210, Topeka, KS 66606-1679 Ph: (785) 235-3451 | Roger B Moss, CRNA 823 Sw Mulvane St, Suite 210, Topeka, KS 66606-1679 Ph: (785) 235-3451 |
News Archive
Temple University School of Medicine announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Laura Goetzl, MD, MPH, Professor of Obstetrics, Gynecology and Reproductive Sciences; and Vice Chair of Research and Academic Development at Temple University School of Medicine will pursue an innovative global health and development research project, titled "Maternal Blood Biomarkers to Assess Fetal Neurodevelopment."
At the 2010 ACC conference held in Atlanta, GA, six new studies based on the PAT™ (Peripheral Arterial Tone) signal focused on assessing cardiovascular risk by measuring and improving endothelial health. Of those, two studies from Japan focused on assessing cardiovascular risk in both high and low risk patient populations.
A new study offers the first evidence of a drug capable of preventing lethal damage to the gastrointestinal (GI) tract caused by exposure to high levels of ionizing radiation, such as those occurring during a nuclear incident.
Genetic Immunity, a multi-national biopharmaceutical company developing nanomedicine vaccines today announces publication of the Company's innovative work to develop a stable liquid formulation to deliver a novel nanomedicine. Appearing in the International Journal of Pharmaceutics, the paper addresses how Genetic Immunity was able to overcome significant hurdles facing the field to successfully formulate the first topically administered nanomedicine therapeutic vaccine for the treatment of HIV/AIDS, DermaVir.
A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.
› Verified 9 days ago
Roger Vickery, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw 6th Ave, Topeka, KS 66606 Phone: 785-354-8518 Fax: 785-354-1255 | |
Shannon Schwarz, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 785-295-8111 | |
Michelle D Andrews, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 823 Sw Mulvane St, Suite 210, Topeka, KS 66606 Phone: 785-235-3451 Fax: 785-235-1435 | |
Lindsey E Dunn, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-6000 | |
Donald I Pekrul, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 823 Sw Mulvane St, Suite 210, Topeka, KS 66606 Phone: 785-235-3451 Fax: 785-235-1435 | |
Laci Lee Hansen, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 823 Sw Mulvane St, Suite 210, Topeka, KS 66606 Phone: 785-235-3451 | |
Brett Barkemeyer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 952-442-9770 |